$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix

$cpix Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-K Financial Statement

#000162828016012682 Filed on March 14, 2016

Income Statement

Concept	2014 Q4	2014 Q3	2014 Q2
Revenue	$9.329M	$9.729M	$9.750M
YoY Change	14.34%	49.02%	37.69%
Cost Of Revenue	$1.360M	$1.340M	$1.299M
YoY Change	-36.74%	29.95%	12.47%
Gross Profit	$7.970M	$8.389M	$8.451M
YoY Change	32.61%	52.6%	42.61%
Gross Profit Margin	85.43%	86.23%	86.68%
Selling, General & Admin	$5.740M	$5.980M	$6.070M
YoY Change	-16.33%	11.38%	12.47%
% of Gross Profit	72.02%	71.28%	71.83%
Research & Development	$770.0K	$934.8K	$861.2K
YoY Change	-42.54%	-35.11%	-37.91%
% of Gross Profit	9.66%	11.14%	10.19%
Depreciation & Amortization	$610.0K	$580.0K	$400.0K
YoY Change	60.53%	87.1%	25.0%
% of Gross Profit	7.65%	6.91%	4.73%
Operating Expenses	$7.020M	$6.915M	$6.931M
YoY Change	-17.22%	1.55%	2.17%
Operating Profit	$946.1K	$989.0K	$1.216M
YoY Change	-138.27%	-165.29%	-206.58%
Interest Expense	$30.00K	$26.88K	$12.28K
YoY Change	0.0%	10.67%	-40.69%
% of Operating Profit	3.17%	2.72%	1.01%
Other Income/Expense, Net
YoY Change
Pretax Income	$980.0K	$1.070M	$1.233M
YoY Change	-140.16%	-170.47%	-210.84%
Income Tax	$330.0K	$341.0K	$523.3K
% Of Pretax Income	33.67%	31.86%	42.45%
Net Earnings	$668.9K	$745.9K	$722.6K
YoY Change	-144.58%	-190.97%	-213.08%
Net Earnings / Revenue	7.17%	7.67%	7.41%
Basic Earnings Per Share	$0.04	$0.04	$0.04
Diluted Earnings Per Share	$0.04	$0.04	$0.04
COMMON SHARES
Basic Shares Outstanding	17.36M shares	17.54M shares	17.74M shares
Diluted Shares Outstanding		17.85M shares	18.03M shares

Balance Sheet

Concept	2014 Q4	2014 Q3	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$54.71M	$54.28M	$53.88M
YoY Change	-0.33%	-16.72%	-22.12%
Cash & Equivalents	$39.87M	$39.64M	$39.05M
Short-Term Investments	$14.84M	$14.63M	$14.83M
Other Short-Term Assets	$5.002M	$4.445M	$3.744M
YoY Change	41.42%	28.25%	17.1%
Inventory	$5.600M	$6.131M	$6.997M
Prepaid Expenses
Receivables	$5.505M	$5.296M	$6.014M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$70.81M	$70.15M	$70.63M
YoY Change	3.11%	-10.37%	-14.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$651.0K	$731.1K	$726.9K
YoY Change	-26.07%	-25.01%	-31.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.792M	$3.025M	$3.036M
YoY Change	33.17%	111.56%	130.1%
Total Long-Term Assets	$24.59M	$23.75M	$22.84M
YoY Change	29.87%	74.14%	75.34%
TOTAL ASSETS
Total Short-Term Assets	$70.81M	$70.15M	$70.63M
Total Long-Term Assets	$24.59M	$23.75M	$22.84M
Total Assets	$95.41M	$93.90M	$93.47M
YoY Change	8.89%	2.17%	-2.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.243M	$3.205M	$4.220M
YoY Change	59.28%	41.07%	36.4%
Accrued Expenses	$10.51M
YoY Change	90.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.75M	$12.16M	$11.86M
YoY Change	82.21%	124.61%	94.65%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$902.8K	$900.0K	$900.0K
YoY Change	16.33%	28.57%	50.0%
Total Long-Term Liabilities	$902.8K	$900.0K	$900.0K
YoY Change	16.33%	-83.93%	-86.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.75M	$12.16M	$11.86M
Total Long-Term Liabilities	$902.8K	$900.0K	$900.0K
Total Liabilities	$14.65M	$13.02M	$12.74M
YoY Change	76.07%	18.58%	1.14%
SHAREHOLDERS EQUITY
Retained Earnings	$18.82M	$18.15M	$17.40M
YoY Change	14.78%	1.42%	-7.01%
Common Stock	$61.94M	$62.95M	$63.53M
YoY Change	-1.79%	-0.39%	-1.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$80.76M	$81.10M	$80.93M
YoY Change
Total Liabilities & Shareholders Equity	$95.41M	$93.90M	$93.47M
YoY Change	8.89%	2.17%	-2.09%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2014 Q2
OPERATING ACTIVITIES
Net Income	$668.9K	$745.9K	$722.6K
YoY Change	-144.58%	-190.97%	-213.08%
Depreciation, Depletion And Amortization	$610.0K	$580.0K	$400.0K
YoY Change	60.53%	87.1%	25.0%
Cash From Operating Activities	$2.730M	$2.140M	$840.0K
YoY Change	-1536.84%	-351.76%	600.0%
INVESTING ACTIVITIES
Capital Expenditures	-$1.490M	-$990.0K	-$360.0K
YoY Change	-69.4%	25.32%	-59.09%
Acquisitions
YoY Change
Other Investing Activities	-$20.00K	$240.0K	-$1.340M
YoY Change	-100.39%	-14.29%	119.67%
Cash From Investing Activities	-$1.510M	-$750.0K	-$1.700M
YoY Change	-729.17%	44.23%	14.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.000M	-790.0K	860.0K
YoY Change	-80.69%	-65.35%	-577.78%
NET CHANGE
Cash From Operating Activities	2.730M	2.140M	840.0K
Cash From Investing Activities	-1.510M	-750.0K	-1.700M
Cash From Financing Activities	-1.000M	-790.0K	860.0K
Net Change In Cash	220.0K	600.0K	0.0000000001164
YoY Change	-104.29%	-116.44%	-100.0%
FREE CASH FLOW
Cash From Operating Activities	$2.730M	$2.140M	$840.0K
Capital Expenditures	-$1.490M	-$990.0K	-$360.0K
Free Cash Flow	$4.220M	$3.130M	$1.200M
YoY Change	-9.83%	-5316.67%	20.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	cpix	Accrued Acquisition Costs AccruedAcquisitionCosts	2360960	USD
CY2015Q4	cpix	Accrued Acquisition Costs AccruedAcquisitionCosts	0	USD
CY2013	cpix	Deferred Income Tax Expense Benefit Allowancefor Accounts Receivable DeferredIncomeTaxExpenseBenefitAllowanceforAccountsReceivable	-161084	USD
CY2014	cpix	Deferred Income Tax Expense Benefit Allowancefor Accounts Receivable DeferredIncomeTaxExpenseBenefitAllowanceforAccountsReceivable	63438	USD
CY2015	cpix	Deferred Income Tax Expense Benefit Allowancefor Accounts Receivable DeferredIncomeTaxExpenseBenefitAllowanceforAccountsReceivable	26808	USD
CY2013	cpix	Deferred Income Tax Expense Benefit Before Reconciling Items DeferredIncomeTaxExpenseBenefitBeforeReconcilingItems	-60739	USD
CY2014	cpix	Deferred Income Tax Expense Benefit Before Reconciling Items DeferredIncomeTaxExpenseBenefitBeforeReconcilingItems	-85844	USD
CY2015	cpix	Deferred Income Tax Expense Benefit Before Reconciling Items DeferredIncomeTaxExpenseBenefitBeforeReconcilingItems	-26193	USD
CY2013	cpix	Deferred Income Tax Expense Benefit Change In Valuation Allowance Due To Changes In Net Deferred Tax Asset Balances DeferredIncomeTaxExpenseBenefitChangeInValuationAllowanceDueToChangesInNetDeferredTaxAssetBalances	23299	USD
CY2014	cpix	Deferred Income Tax Expense Benefit Change In Valuation Allowance Due To Changes In Net Deferred Tax Asset Balances DeferredIncomeTaxExpenseBenefitChangeInValuationAllowanceDueToChangesInNetDeferredTaxAssetBalances	20457	USD
CY2015	cpix	Deferred Income Tax Expense Benefit Change In Valuation Allowance Due To Changes In Net Deferred Tax Asset Balances DeferredIncomeTaxExpenseBenefitChangeInValuationAllowanceDueToChangesInNetDeferredTaxAssetBalances	33405	USD
CY2013	cpix	Deferred Income Tax Expense Benefit Compensation And Benefits Share Based Compensation Cost DeferredIncomeTaxExpenseBenefitCompensationAndBenefitsShareBasedCompensationCost	-127308	USD
CY2014	cpix	Deferred Income Tax Expense Benefit Compensation And Benefits Share Based Compensation Cost DeferredIncomeTaxExpenseBenefitCompensationAndBenefitsShareBasedCompensationCost	-298039	USD
CY2015	cpix	Deferred Income Tax Expense Benefit Compensation And Benefits Share Based Compensation Cost DeferredIncomeTaxExpenseBenefitCompensationAndBenefitsShareBasedCompensationCost	972	USD
CY2013	cpix	Deferred Income Tax Expense Benefit Creation Utilization Of Operating Loss Carryforwards DeferredIncomeTaxExpenseBenefitCreationUtilizationOfOperatingLossCarryforwards	-788342	USD
CY2014	cpix	Deferred Income Tax Expense Benefit Creation Utilization Of Operating Loss Carryforwards DeferredIncomeTaxExpenseBenefitCreationUtilizationOfOperatingLossCarryforwards	-17424	USD
CY2015	cpix	Deferred Income Tax Expense Benefit Creation Utilization Of Operating Loss Carryforwards DeferredIncomeTaxExpenseBenefitCreationUtilizationOfOperatingLossCarryforwards	-34465	USD
CY2013	cpix	Deferred Income Tax Expense Benefit Creation Utilization Of Tax Credit Carryforwards DeferredIncomeTaxExpenseBenefitCreationUtilizationOfTaxCreditCarryforwards	-196631	USD
CY2014	cpix	Deferred Income Tax Expense Benefit Creation Utilization Of Tax Credit Carryforwards DeferredIncomeTaxExpenseBenefitCreationUtilizationOfTaxCreditCarryforwards	-43398	USD
CY2015	cpix	Deferred Income Tax Expense Benefit Creation Utilization Of Tax Credit Carryforwards DeferredIncomeTaxExpenseBenefitCreationUtilizationOfTaxCreditCarryforwards	-35272	USD
CY2013	cpix	Deferred Income Tax Expense Benefit Deferred Charges DeferredIncomeTaxExpenseBenefitDeferredCharges	-83755	USD
CY2014	cpix	Deferred Income Tax Expense Benefit Deferred Charges DeferredIncomeTaxExpenseBenefitDeferredCharges	-838556	USD
CY2015	cpix	Deferred Income Tax Expense Benefit Deferred Charges DeferredIncomeTaxExpenseBenefitDeferredCharges	59028	USD
CY2013	cpix	Deferred Income Tax Expense Benefit Intangible Assets DeferredIncomeTaxExpenseBenefitIntangibleAssets	18565	USD
CY2014	cpix	Deferred Income Tax Expense Benefit Intangible Assets DeferredIncomeTaxExpenseBenefitIntangibleAssets	1023948	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4968170	USD
CY2015	cpix	Deferred Income Tax Expense Benefit Intangible Assets DeferredIncomeTaxExpenseBenefitIntangibleAssets	239758	USD
CY2013	cpix	Deferred Income Tax Expense Benefit Inventory Write Downs DeferredIncomeTaxExpenseBenefitInventoryWriteDowns	-310477	USD
CY2014	cpix	Deferred Income Tax Expense Benefit Inventory Write Downs DeferredIncomeTaxExpenseBenefitInventoryWriteDowns	83418	USD
CY2015	cpix	Deferred Income Tax Expense Benefit Inventory Write Downs DeferredIncomeTaxExpenseBenefitInventoryWriteDowns	257970	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1351324	USD
CY2013	cpix	Deferred Income Tax Expense Benefit Reservefor Expired Products DeferredIncomeTaxExpenseBenefitReserveforExpiredProducts	106554	USD
CY2014	cpix	Deferred Income Tax Expense Benefit Reservefor Expired Products DeferredIncomeTaxExpenseBenefitReserveforExpiredProducts	-217330	USD
CY2015	cpix	Deferred Income Tax Expense Benefit Reservefor Expired Products DeferredIncomeTaxExpenseBenefitReserveforExpiredProducts	-31784	USD
CY2014Q4	cpix	Deferred Tax Assets Deferred Charges DeferredTaxAssetsDeferredCharges	1504835	USD
CY2015Q4	cpix	Deferred Tax Assets Deferred Charges DeferredTaxAssetsDeferredCharges	660973	USD
CY2014Q4	cpix	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	2205260	USD
CY2015Q4	cpix	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	2274994	USD
CY2014Q4	cpix	Deferred Tax Assets Property And Equipment And Intangibles DeferredTaxAssetsPropertyAndEquipmentAndIntangibles	300301	USD
CY2015Q4	cpix	Deferred Tax Assets Property And Equipment And Intangibles DeferredTaxAssetsPropertyAndEquipmentAndIntangibles	326499	USD
CY2014Q4	cpix	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves For Expired Product DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct	817736	USD
CY2015Q4	cpix	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves For Expired Product DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct	849579	USD
CY2015	cpix	Defined Contribution Plan Eligibility Minimum Employee Age DefinedContributionPlanEligibilityMinimumEmployeeAge	P21Y
CY2015	cpix	Defined Contribution Plan Eligibility Minimum Employee Service Time For Participation Eligibility DefinedContributionPlanEligibilityMinimumEmployeeServiceTimeForParticipationEligibility	P6M
CY2013	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	400000	USD
CY2014	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	400000	USD
CY2015	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	300000	USD
CY2015Q4	cpix	Finite Lived Intangible Assets Amortization Expense Year Fiveand After FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveandAfter	12754384	USD
CY2014Q1	cpix	Inventory Extended Shelf Life InventoryExtendedShelfLife	P6Y
CY2015Q1	cpix	Inventory Extended Shelf Life InventoryExtendedShelfLife	P7Y
CY2014Q1	cpix	Inventory Shelf Life InventoryShelfLife	P5Y
CY2015Q1	cpix	Inventory Shelf Life InventoryShelfLife	P6Y
CY2014Q2	cpix	Loans Forgivenin Exchange For Share Issued Amount LoansForgiveninExchangeForShareIssuedAmount	2400000	USD
CY2015Q4	cpix	Manufacturing Agreements Number Of Primary Suppliers For Each Product ManufacturingAgreementsNumberOfPrimarySuppliersForEachProduct	1	supplier
CY2014Q4	cpix	Net Deferred Tax Assets Gross NetDeferredTaxAssetsGross	4381811	USD
CY2015Q4	cpix	Net Deferred Tax Assets Gross NetDeferredTaxAssetsGross	3925007	USD
CY2015Q4	cpix	Operating Leases Future Minimum Payments Due In Five Years And Thereafter OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter	2469052	USD
CY2014Q4	cpix	Product Sales Related Liabilities Current ProductSalesRelatedLiabilitiesCurrent	5234800	USD
CY2015Q4	cpix	Product Sales Related Liabilities Current ProductSalesRelatedLiabilitiesCurrent	6776023	USD
CY2013	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	543905	USD
CY2014	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	-1574847	USD
CY2015	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	967146	USD
CY2015	cpix	Revenue Recognition Cumulative Upfront Payment RevenueRecognitionCumulativeUpfrontPayment	1500000	USD
CY2015	cpix	Revenue Recognition Potential Upfront Payment Relatedto Product Sales RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales	4700000	USD
CY2015	cpix	Revenue Recognition Potential Upfront Payments Relatedto Regulatory Approval RevenueRecognitionPotentialUpfrontPaymentsRelatedtoRegulatoryApproval	1700000	USD
CY2015	cpix	Revenue Recognition Upfront Payment RevenueRecognitionUpfrontPayment	1400000	USD
CY2015	cpix	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans	3	plan
CY2015	cpix	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans Available For Future Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlansAvailableForFutureGrants	2	plan
CY2013	cpix	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	0.12
CY2014	cpix	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	0.00
CY2015	cpix	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	3.26
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0001087294
CY2016Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16306980	shares
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2015Q2	dei	Entity Public Float EntityPublicFloat	60943000	USD
CY2015	dei	Entity Registrant Name EntityRegistrantName	CUMBERLAND PHARMACEUTICALS INC
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3242713	USD
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2877479	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2423723	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	731351	USD
CY2015	us-gaap	Advertising Expense AdvertisingExpense	2600000	USD
CY2013	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	24075	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5504728	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6077120	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10506769	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9534268	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2239527	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2497072	USD
CY2013	us-gaap	Advertising Expense AdvertisingExpense	2100000	USD
CY2014	us-gaap	Advertising Expense AdvertisingExpense	2500000	USD
CY2014	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	38634	USD
CY2015	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	46422	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	896156	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1596689	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1989264	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	407954	shares
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	194237	shares
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	46633	shares
CY2014Q4	us-gaap	Assets Assets	95405114	USD
CY2015Q4	us-gaap	Assets Assets	91918959	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	70814971	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	67112074	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54349381	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40869457	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39866037	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38203059	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-13479924	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1003420	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1662978	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2015Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17118993	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16379501	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17118993	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16379501	shares
CY2014Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	61942410	USD
CY2015Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	57338294	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2151418	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2362465	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	671108	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2104614	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5439422	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	250064	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	44276	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5053165	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	85602	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	11580	USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	35828800	USD
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	33343035	USD
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	32407441	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	45287	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1440010	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	41326	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	56867	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1690074	USD
CY2014Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	600000	USD
CY2015Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	700000	USD
CY2014Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	1700000	USD
CY2015Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	1800000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1426701	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-213552	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	385723	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1579918	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-309330	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	490227	USD
CY2013	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1579918	USD
CY2014	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-309330	USD
CY2015	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	490227	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-153217	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-95778	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	104504	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8089346	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7087509	USD
CY2014Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1412477	USD
CY2015Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1154507	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4229737	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3739510	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	3651145	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	2528724	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	578592	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	1210786	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1676729	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1675757	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	172008	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	145200	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	152074	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	185497	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3707535	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3162502	USD
CY2013	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	50000	USD
CY2014	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	50000	USD
CY2015	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	50000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1301835	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1989564	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2246809	USD
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.42
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.37
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.46
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.00
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.01
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.10
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.01
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.02
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.01
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.05
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.05
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.01
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.03
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1154093	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1034991	USD
CY2015Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1800000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M1D
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	48024	USD
CY2014	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1653028	USD
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	90982	USD
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	48024	USD
CY2014	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1653028	USD
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	90982	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2103553	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2103553	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2103553	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2103553	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21568541	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21168596	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9489976	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8401560	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7607588	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3674469	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3743209	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1246937	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1523051	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1380744	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	575829	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	-129509	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	17077	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	52238	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	58855	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3846482	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1475964	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1486777	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	974304	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	572392	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-495473	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1532563	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1330176	USD
CY2013	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	187673	USD
CY2014	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	162127	USD
CY2015	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2731	USD
CY2013	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-117021	USD
CY2014	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1011365	USD
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	263084	USD
CY2013	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2014	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	281867	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	378784	shares
CY2013	us-gaap	Interest Expense InterestExpense	103422	USD
CY2014	us-gaap	Interest Expense InterestExpense	67074	USD
CY2015	us-gaap	Interest Expense InterestExpense	73856	USD
CY2013	us-gaap	Interest Paid InterestPaid	79347	USD
CY2014	us-gaap	Interest Paid InterestPaid	28440	USD
CY2015	us-gaap	Interest Paid InterestPaid	27434	USD
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3028854	USD
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1693522	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	5600319	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	4270143	USD
CY2014Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2571465	USD
CY2015Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2576621	USD
CY2014Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3200000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	14652323	USD
CY2015Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2700000	USD
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	230291	USD
CY2014	us-gaap	Investment Income Interest InvestmentIncomeInterest	251447	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1000000	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	209183	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	900000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1000000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	15099176	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12411747	USD
CY2014Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2015Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	1700000	USD
CY2014Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	14841418	USD
CY2015Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	14564115	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	95405114	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	91918959	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13749482	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	-7882	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	-68125	USD
CY2014Q1	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.85
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9154111	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1662411	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5194871	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5071939	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6034440	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2344972	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	746126	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6693431	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5876865	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-2104614	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	286320	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	722570	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	745920	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	668913	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	2423723	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	46281	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	407398	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	126613	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	151059	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	731351	USD
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-46804	USD
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-61258	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-60243	USD
CY2014	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	1000005	USD
CY2015	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-3801338	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	408051	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1215609	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	989038	USD
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	946138	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	3558836	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	4116	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	673931	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	270884	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	162679	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	1111610	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	6324377	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1075243	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	100000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	838896	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	901568	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1039618	USD
CY2013	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	500000	USD
CY2014	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	500000	USD
CY2015	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	600000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1791980	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1891053	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-46804	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-61258	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-60243	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1756916	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1723254	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	902841	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	987429	USD
CY2013	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-178822	USD
CY2014	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	52040	USD
CY2015	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	77155	USD
CY2013	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	926764	USD
CY2014	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	218109	USD
CY2015	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	505867	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4800908	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4315444	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5338967	USD
CY2013	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2014	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2015	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1668252	USD
CY2013	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
CY2014	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	2000000	USD
CY2015	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	7462080	USD
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3101565	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2556465	USD
CY2014Q2	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	1000000	USD
CY2013	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4371508	USD
CY2014	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4207262	USD
CY2015	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	7528713	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	97412	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	163258	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	142965	USD
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	-41276	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	21366	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1468913	USD
CY2013	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2013	us-gaap	Profit Loss ProfitLoss	-2151418	USD
CY2015	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	7883171	USD
CY2014	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	1000005	USD
CY2015	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2013	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-4359951	USD
CY2014	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	USD
CY2015	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1700000	USD
CY2013	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	6859061	USD
CY2014	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	3437645	USD
CY2014	us-gaap	Profit Loss ProfitLoss	2362465	USD
CY2015	us-gaap	Profit Loss ProfitLoss	671108	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2890557	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3033522	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	651030	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	536450	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5615501	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3389419	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3847651	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	18818263	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	19549614	USD
CY2013	us-gaap	Revenues Revenues	800000	USD
CY2014	us-gaap	Revenues Revenues	600000	USD
CY2015	us-gaap	Revenues Revenues	900000	USD
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	31100698	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	36683762	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	33013184	USD
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	32027462	USD
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	8093244	USD
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	9750168	USD
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	9729047	USD
CY2014Q4	us-gaap	Sales Revenue Net SalesRevenueNet	9329412	USD
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	36901871	USD
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	8686774	USD
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	8909741	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	7885048	USD
CY2015Q4	us-gaap	Sales Revenue Net SalesRevenueNet	8037488	USD
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	33519051	USD
CY2013	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14387745	USD
CY2014	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14902202	USD
CY2015	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13994768	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	674955	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	761663	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	622503	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12300	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.89
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	76819783	USD
CY2014Q4	us-gaap	Trading Securities TradingSecurities	14841418	USD
CY2015Q4	us-gaap	Trading Securities TradingSecurities	14564115	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	360	USD
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18332997	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	212444	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3875	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	198140	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	140404	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	6.46
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	7.41
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2320	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	356496	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	158356	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12300	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.96
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.62
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.89
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.75
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y7M5D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y0M5D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5M
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y7M5D
CY2013	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	900000	USD
CY2014	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	1000000	USD
CY2015	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	800000	USD
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5652	shares
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	670934	USD
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	760894	USD
CY2015	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	622503	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6748	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1653028	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	112348	USD
CY2013	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4800908	USD
CY2014	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4315444	USD
CY2015	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5338967	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	80760673	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	76887908	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	85566487	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	79291843	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	80752791	USD
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17899632	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17094754	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18332997	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17617765	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16715970	shares
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-left:4px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:10px;text-align:justify;padding-left:24px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-16-012682-index-headers.html	Edgar Link	pending
0001628280-16-012682-index.html	Edgar Link	pending
0001628280-16-012682.txt	Edgar Link	pending
0001628280-16-012682-xbrl.zip	Edgar Link	pending
a2015-10k.htm	Edgar Link	pending
a2015-10kxexhibit1011ajkaz.htm	Edgar Link	pending
a2015-10kxexhibit1012marti.htm	Edgar Link	pending
a2015-10kxexhibit1013leopa.htm	Edgar Link	pending
a2015-10kxexhibit1014micha.htm	Edgar Link	pending
a2015-10kxexhibit1015jimhe.htm	Edgar Link	pending
a2015-10kxexhibit1025gelli.htm	Edgar Link	pending
a2015-10kxexhibit231consen.htm	Edgar Link	pending
a2015-10kxexhibit311.htm	Edgar Link	pending
a2015-10kxexhibit312.htm	Edgar Link	pending
a2015-10kxexhibit321.htm	Edgar Link	pending
a2015-10k_chartx06448.jpg	Edgar Link	pending
a20160309cumberlandge_image1.gif	Edgar Link	pending
cpix-20151231.xml	Edgar Link	completed
cpix-20151231.xsd	Edgar Link	pending
cpix-20151231_cal.xml	Edgar Link	unprocessable
cpix-20151231_def.xml	Edgar Link	unprocessable
cpix-20151231_lab.xml	Edgar Link	unprocessable
cpix-20151231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix

2014 Q4 Form 10-K Financial Statement

#000162828016012682 Filed on March 14, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPIX CUMBERLAND PHARMACEUTICALS INC Stock $cpix

2014 Q4 Form 10-K Financial Statement

#000162828016012682 Filed on March 14, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix